Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mapstone

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Scientific Reports|May 29, 2024
Cerebrovascular disease emerges with age and Alzheimer's disease in adults with Down syndromePatrick Lao, Natalie Edwards, Lisi Flores-Aguilar, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 7, 2012
The pill questionnaire in a nondemented Parkinson's disease populationWilliam Reginold, Melissa J Armstrong, Sarah Duff-Canning, et al.
Journal of Alzheimer'S Disease : JAD|December 24, 2022
Weight Loss and Alzheimer's Disease in Down SyndromeVictoria Fleming, Brian C Helsel, Lauren T Ptomey, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 7, 2026
Intraindividual cognitive variability predicts amyloid beta, tau PET, and dementia conversion in Down syndrome: a potential marker of cognitive resilienceLuciana Mascarenhas Fonseca, Eardi Lila, Ali Shojaie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Longitudinal changes in white matter hyperintensity volume accelerate across the Alzheimer's continuum in adults with Down syndromePatrick Lao, Natalie Edwards, Lisi Flores-Aguilar, et al.
Dialogues in Clinical Neuroscience|October 23, 2019
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease
Harald Hampel, Andrea Vergallo, Mohammad Afshar, et al.
Neurobiology of Aging|May 8, 2026
The TREM2 R47H variant is associated with liver-plasma-brain axis dyshomeostasis in the 5xFAD mouse model of Alzheimer's diseaseGina Faraci, Benjamin Goodfriend, Joseph Bishop, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's diseaseSaira S Mirza, Sarah Duff-Canning, Mark Mapstone, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 20, 2025
Characterization of plasma AT(N) biomarkers among a racial and ethnically diverse community-based cohort: an HABS-HD studyMelissa E Petersen, Fan Zhang, James Hall, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Scientific Reports|May 29, 2024
Cerebrovascular disease emerges with age and Alzheimer's disease in adults with Down syndromePatrick Lao, Natalie Edwards, Lisi Flores-Aguilar, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 7, 2012
The pill questionnaire in a nondemented Parkinson's disease populationWilliam Reginold, Melissa J Armstrong, Sarah Duff-Canning, et al.
Journal of Alzheimer'S Disease : JAD|December 24, 2022
Weight Loss and Alzheimer's Disease in Down SyndromeVictoria Fleming, Brian C Helsel, Lauren T Ptomey, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 7, 2026
Intraindividual cognitive variability predicts amyloid beta, tau PET, and dementia conversion in Down syndrome: a potential marker of cognitive resilienceLuciana Mascarenhas Fonseca, Eardi Lila, Ali Shojaie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Longitudinal changes in white matter hyperintensity volume accelerate across the Alzheimer's continuum in adults with Down syndromePatrick Lao, Natalie Edwards, Lisi Flores-Aguilar, et al.
Dialogues in Clinical Neuroscience|October 23, 2019
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease
Harald Hampel, Andrea Vergallo, Mohammad Afshar, et al.
Neurobiology of Aging|May 8, 2026
The TREM2 R47H variant is associated with liver-plasma-brain axis dyshomeostasis in the 5xFAD mouse model of Alzheimer's diseaseGina Faraci, Benjamin Goodfriend, Joseph Bishop, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's diseaseSaira S Mirza, Sarah Duff-Canning, Mark Mapstone, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 20, 2025
Characterization of plasma AT(N) biomarkers among a racial and ethnically diverse community-based cohort: an HABS-HD studyMelissa E Petersen, Fan Zhang, James Hall, et al.
Pageof 15